STOCK TITAN

Morgan Stanley lists KLRS restricted stock vesting parcels (KLRS) in Form 144 notice

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 reporting proposed sales tied to multiple parcels of restricted Common stock that vest under a registered plan. The notice lists individual vesting dates and share quantities, including 1,098 shares vesting on 03/18/2025 and smaller tranches across 2024–2025.

The filing enumerates vesting events labeled "Restricted stock vesting under a registered plan" with specific dates and share counts; these entries reflect planned dispositions associated with service‑based vesting rather than an open‑market transaction detail or aggregate registered amount.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 notice listing vested restricted shares and proposed sales.

The filing lists multiple vesting events for Common stock under a registered plan, each with a date and share count. The filings are structured as notices of proposed sales tied to vesting; they do not in themselves consummate sales.

Regulatory effect: these entries preserve an affiliate's right to sell under Rule 144 when conditions are met. Subsequent transaction details and proceeds treatment are expected in later trade reports or issuer disclosures.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Morgan Stanley's Form 144 for KLRS show?

It lists proposed sales tied to multiple restricted Common stock vesting events. The notice includes specific vesting dates and share counts, for example 1,098 shares on 03/18/2025, and numerous smaller tranches dated in 2024 and 2025.

Does the Form 144 mean KLRS shares were already sold?

No, the Form 144 is a notice of proposed sale associated with vested restricted shares. It enumerates vesting events and share quantities but does not itself report completed open‑market sales or aggregate proceeds.

Which vesting parcels are largest in the filing for KLRS?

The largest single parcel shown is 1,098 shares vesting on 03/18/2025. The filing also shows multiple smaller tranches (for example, 105 shares on 05/02/2024 and 101 shares on 02/02/2025), each listed with a vesting date.

Are the listed KLRS shares described as restricted or unrestricted?

They are described as "Restricted stock vesting under a registered plan", indicating the entries reflect service‑based vesting events under the issuer's registered plan rather than already free trading unrestricted shares.

Will the Form 144 show how proceeds are used for KLRS?

The filing enumerates vesting dates and share counts but does not provide instructions on use of sale proceeds. Details about proceeds or completed transactions would appear in subsequent trade reports or issuer disclosures.
Kalaris Therapeutics Inc

NASDAQ:KLRS

View KLRS Stock Overview

KLRS Rankings

KLRS Latest News

KLRS Latest SEC Filings

KLRS Stock Data

127.36M
16.34M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
BERKELEY HEIGHTS